Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Cancer cell (3D)
[{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591c3/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591c3/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591c2/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591c2/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591c1/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591c1/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591c0/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591c0/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591bf/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591bf/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591be/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591be/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591bd/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591bd/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591bc/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591bc/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591bb/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591bb/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591ba/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591ba/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591b9/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591b9/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591b8/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591b8/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591b7/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591b7/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591b6/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591b6/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591b5/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591b5/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591b4/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591b4/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591b3/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591b3/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591b2/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591b2/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591b1/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591b1/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591b0/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591b0/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591af/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591af/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591ae/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591ae/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591ad/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591ad/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591ac/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591ac/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591ab/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591ab/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591aa/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591aa/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591a9/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591a9/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591a8/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591a8/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591a7/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591a7/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591a6/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591a6/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591a5/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591a5/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591a4/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591a4/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591a3/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591a3/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591a2/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591a2/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591a1/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591a1/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d591a0/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d591a0/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d5919f/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d5919f/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d5919e/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d5919e/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d5919d/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d5919d/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d5919c/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d5919c/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d5919b/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d5919b/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d5919a/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d5919a/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d59199/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d59199/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d59198/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d59198/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d59197/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d59197/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d59196/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d59196/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d59195/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d59195/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d59194/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d59194/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d59193/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d59193/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d59192/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d59192/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d59191/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d59191/644a9a55c563ad0020d59126.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/644a9cd1c563ad0020d59190/644a9a55c563ad0020d59126.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/644a9cd1c563ad0020d59190/644a9a55c563ad0020d59126.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
cancer cell,cancer,tumor cell,cancerous oncological,oncology,metastatic,metastasis,abnormal,carcinoma,leukaemia,leukemia,lymphoma,sarcoma,myeloma,3d cell,three-dimensional,3d,3-d,3d,3 dimensional,three dimensional,proj-premium-content-21q2,proj-premium-content-21q2-3dcells,cancer,tumor,3d cancer cell
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
